Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer

NCT01494363 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Cancer

Interventions

DRUG: Fluorouracil
DRUG: Leucovorin
DRUG: Oxaliplatin
DRUG: Irinotecan

Sponsor

Soon Chun Hyang University